Report copyright - ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ...Genotype 4 Daklinza + peginterferon alfa + ribavirin 24 weeks of Daklinza in combination with 24-48 weeks of peginterferon alfa and ribavirin
Please pass captcha verification before submit form